Notice Number: NOT-EB-18-017
Key Dates
Release Date: May 21, 2018
Estimated Publication Date of Funding Opportunity Announcement: November 6, 2018
First Estimated Application Due Date: January 11, 2019
Earliest Estimated Award Date: April 1, 2019
Earliest Estimated Start Date: May 1, 2019
Issued by
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Purpose
The purpose of this Notice is to inform potential applicants that the National Institute of Biomedical Imaging and Bioengineering (NIBIB) intends to re-issue PA-18-426. This administrative supplement is to facilitate collaboration by supporting multidisciplinary research teams comprised of quantitative researchers and clinician-scientists from active CTSA institutions (PAR-15-304, PAR-18-464). This supplement will support translational team research projects by providing salary and research support to a quantitative researcher with a background in engineering or computational or physical sciences, contingent upon his/her collaborating with a clinician-scientist KL2 scholar. The collaborating KL2 clinician-scientist will be supported independently of this supplement through the parent KL2 award throughout the duration of the proposed supplement. Both team members will be selected by the KL2 PD/PI. The KL2 PD/PI will assist the quantitative researcher and clinician-scientist in developing a translational research project aligned with NIBIB’s research mission under the guidance of their identified basic and clinical science mentors. Based on this, the KL2 PD/PI will submit a supplement request under the re-issued FOA.
Research Initiative Details Funding Information TBD
Estimated Total Funding TBD
Expected Number of Awards TBD
Estimated Award Ceiling TBD
Primary CFDA Numbers TBD
Anticipated Eligible Organizations
Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Inquiries
Please direct all inquiries to:
Zeynep Erim
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
301-451- 4797
[email protected]